SCNI
Scinai Immunotherapeutics
SCNI
SCNI
3 hedge funds and large institutions have $102K invested in Scinai Immunotherapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EWM
1
Edge Wealth Management
New York
|
$1K |
Top Sellers
| 1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$44K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
| $57K | – | – | – |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $44K | -$11K | -30 | -20% |
|
|
EWM
3
Edge Wealth Management
New York
| $1K | +$1K | +100 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$2K | -5 | Closed |
|